HISTORICAL FACTS: Irwd | History Defined

3 Stocks Trading Near $5 With Massive Earnings Upside

Some companies have failed to report strong enough earnings growth this past quarter; that's not the case for these three stocks that trade for less than $5

MarketBeat · Feb 8

3 Penny Stocks to Watch for Big Gains in 2025

The Federal Reserve's recent rate cut indicates a stable yet slowing economy, with inflation sticking around but consumer spending strong. In light of these events, penny stocks, Ribbon Communications (RBBN), Ironwood Pharmaceuticals (IRWD), and Organogenesis Holdings (ORGO), all priced under $5, could make attractive investments. Read on….

StockNews.com · Dec 19, 2024

3 High-Risk, High-Reward Penny Stocks to Buy

High-risk, high-reward stocks are highly favored by investors having high risk tolerance to achieve potential returns and yield. Hence, it could be ideal to buy fundamentally solid, high-risk, high-reward penny stocks Taboola.com (TBLA), Ironwood Pharmaceuticals (IRWD), and Castor Maritime (CTRM). Keep reading.

StockNews.com · Sep 3, 2024

Ironwood Pharmaceuticals Q1 2022 Earnings Conference Call On May 5, 2022 At 08:30 AM ET

  Ironwood Pharmaceuticals (NASDAQ:IRWD) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results.

Benzinga · Apr 29, 2022

2 Under-the-Radar Pharmaceutical Stocks to Add to Your Watchlist

Irrespective of worsening supply chain disruptions due to the Russia-Ukraine war, the pharmaceutical industry is expected to witness stable growth given the rising medical needs of an aging population and rapid advancements in the drug development process. So, amid an apparent resurgence of COVID-19 cases, we think it could be…

StockNews.com · Apr 22, 2022

Ironwood Pharmaceuticals Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data Ironwood Pharmaceuticals (NASDAQ:IRWD) posted a 25.91% decrease in earnings from Q3. Sales, however, increased by 12.9% over the previous quarter to $117.13 million.

Benzinga · Feb 18, 2022

Ironwood Reports Mixed Q4 Results; Linzess Joins Blockbuster Club As US Sales Exceed $1B

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) 

Benzinga · Feb 17, 2022

Recap: Ironwood Pharmaceuticals Q4 Earnings

  Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 17, 2022